A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 9, Issue 4, Pages 823-833
Publisher
Informa UK Limited
Online
2013-02-21
DOI
10.4161/hv.22994
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
- (2012) Susanne Hartwig et al. BMC CANCER
- Cost–consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles
- (2011) S. Capri et al. GYNECOLOGIC ONCOLOGY
- Evidence of immune memory 8.5 years following administration of a prophylactic human papillomavirus type 16 vaccine
- (2011) Ali Rowhani-Rahbar et al. JOURNAL OF CLINICAL VIROLOGY
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Economic and Humanistic Burden of External Genital Warts
- (2011) Adam J.N. Raymakers et al. PHARMACOECONOMICS
- The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme
- (2011) T. R. H. Read et al. SEXUALLY TRANSMITTED INFECTIONS
- Economic burden of HPV-related cancers in France
- (2011) I. Borget et al. VACCINE
- HPV vaccination in France: Uptake, costs and issues for the National Health Insurance
- (2011) Jean-Paul Fagot et al. VACCINE
- A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer
- (2010) Nadia Demarteau et al. International Journal of Public Health
- Recurrent respiratory papillomatosis: an uncommon but potentially devastating effect of human papillomavirus in children
- (2010) A J Donne et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
- (2010) Basil Donovan et al. LANCET INFECTIOUS DISEASES
- Economic burden of anal cancer management in France
- (2010) L. Abramowitz et al. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE
- Impact of vaccinating boys and men against HPV in the United States
- (2010) Elamin H. Elbasha et al. VACCINE
- Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
- (2010) N. De Carvalho et al. VACCINE
- Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database
- (2010) Jean Lacau St Guily et al. Head and Neck Optical Diagnostics Society
- Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)
- (2010) Farshid Dayyani et al. Head and Neck Optical Diagnostics Society
- Modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer
- (2010) Nadia Demarteau et al. JOURNAL OF MEDICAL ECONOMICS
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- HPV infection in Europe
- (2009) Hugo De Vuyst et al. EUROPEAN JOURNAL OF CANCER
- A cost–utility analysis of adding a bivalent or quadrivalent HPV vaccine to the Irish cervical screening programme
- (2009) Anne Dee et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- The role of HPV type in Recurrent Respiratory Papillomatosis
- (2009) A.J. Donne et al. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
- Human papillomavirus prevalence and type distribution in penile carcinoma
- (2009) C Miralles-Guri et al. JOURNAL OF CLINICAL PATHOLOGY
- Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
- (2009) Suzanne M. Garland et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis
- (2008) Hugo De Vuyst et al. INTERNATIONAL JOURNAL OF CANCER
- Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France
- (2008) Christine Bergeron et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started